An Oklahoma judge signed off on the agreement with Teva Pharmaceuticals calling for the funds to be used to help abate the state's opioid crisis.
NORMAN, Okla.— A judge in Oklahoma signed off on the state's $85 million settlement with Israeli-owned Teva Pharmaceuticals on Monday following a squabble among the attorney general, the Legislature and the governor over how the deal was structured.
Under the deal, Teva admits to no wrongdoing and agrees to not promote opioids in Oklahoma. The company also agrees to help law enforcement investigate cases of opioid drug diversion or other criminal activity. Balkman said the deal also does not release Teva from any separate claims that might be brought by individual cities or counties. At least nine Oklahoma cities have separately filed claims against similar drug manufacturers, including Teva.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Oklahoma judge approves Teva's $85 million opioid settlementAn Oklahoma judge on Monday approved a revised $85 million settlement with Teva ...
Baca lebih lajut »
Medical marijuana is not the way out of America’s opioid crisisThe evidence for a widely-held theory is thin
Baca lebih lajut »
HuffPost is now a part of Oath
Baca lebih lajut »
Oklahoma judge approves Teva's $85 million opioid settlementAn Oklahoma judge on Monday approved a revised $85 million settlement with Teva ...
Baca lebih lajut »
Alyssa Milano Settles $10 Million Suit With Former AccountantActress Alyssa Milano has settled a legal battle with her former accountant as the case was on the verge of going to trial. Milano and her husband, agent David Bugliari, filed suit in 2017, allegin…
Baca lebih lajut »
Box Office: ‘Toy Story 4’ Launches Overseas With $120 Million, ‘Aladdin’ Clears $800 MillionDisney’s summer box office slate continues to dominate over other studios as “Toy Story 4” launches overseas with a solid $120 million and “Aladdin” crosses $800 milli…
Baca lebih lajut »